Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Telix Pharmaceuticals (Innovations) Pty Limited
Cambridge University Hospitals NHS Foundation Trust
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)